Skip to main content
Erschienen in: Journal of Neuro-Oncology 3/2017

19.05.2017 | Clinical Study

Factors associated with supportive care needs in glioma patients in the neuro-oncological outpatient setting

verfasst von: Mirjam Renovanz, Marlene Hechtner, Mareile Janko, Karoline Kohlmann, Jan Coburger, Minou Nadji-Ohl, Jochem König, Florian Ringel, Susanne Singer, Anne-Katrin Hickmann

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective of this study aimed at assessing glioma patients’ supportive care needs in a neurosurgical outpatient setting and identifying factors that are associated with needs for support. In three neuro-oncological outpatient departments, glioma patients were assessed for their psychosocial needs using the Supportive Care Needs Survey short-form (SCNS-SF34-G). Associations between clinical, sociodemographic, treatment related factors as well as distress (measured with the distress thermometer) and supportive care needs were explored using multivariable general linear models. One-hundred and seventy three of 244 eligible glioma patients participated, most of them with primary diagnoses of a high-grade glioma (81%). Highest need for support was observed in ‘psychological needs’ (median 17.5, range 5–45) followed by ‘physical and daily living needs’ (median 12.5, range 0–25) and ‘health system and information needs’ (median 11.3, range 0–36). Needs in the psychological area were associated with distress (R2 = 0.36) but not with age, sex, Karnofsky performance status (KPS), extend of resection, currently undergoing chemotherapy and whether guidance during assessment was offered. Regarding ‘health system and information needs’, we observed associations with distress, age, currently undergoing chemotherapy and guidance (R2 = 0.31). In the domain ‘physical and daily living needs’ we found associations with KPS, residual tumor, as well as with distress (R2 = 0.37). Glioma patients in neuro-oncological departments report unmet supportive care needs, especially in the psychological domain. Distress is the factor most consistently associated with unmet needs requiring support and could serve as indicator for clinical neuro-oncologists to initiate support.
Literatur
1.
Zurück zum Zitat Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R et al (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol 17(Suppl 4):iv1–iv62CrossRefPubMedPubMedCentral Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R et al (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol 17(Suppl 4):iv1–iv62CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Robin AM, Kalkanis SN, Rock J, Lee I, Rosenblum ML (2014) Through the patient’s eyes: an emphasis on patient-centered values in operative decision making in the management of malignant glioma. J Neurooncol 119:473–479CrossRefPubMed Robin AM, Kalkanis SN, Rock J, Lee I, Rosenblum ML (2014) Through the patient’s eyes: an emphasis on patient-centered values in operative decision making in the management of malignant glioma. J Neurooncol 119:473–479CrossRefPubMed
3.
Zurück zum Zitat Rooney AG, Carson A, Grant R (2011) Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst 103:61–76CrossRefPubMed Rooney AG, Carson A, Grant R (2011) Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst 103:61–76CrossRefPubMed
4.
Zurück zum Zitat Ford E, Catt S, Chalmers A, Fallowfield L (2012) Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro Oncol 14:392–404CrossRefPubMedPubMedCentral Ford E, Catt S, Chalmers A, Fallowfield L (2012) Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro Oncol 14:392–404CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Goebel S, Stark AM, Kaup L, von Harscher M, Mehdorn HM (2011) Distress in patients with newly diagnosed brain tumours. Psychooncology 20:623–630CrossRefPubMed Goebel S, Stark AM, Kaup L, von Harscher M, Mehdorn HM (2011) Distress in patients with newly diagnosed brain tumours. Psychooncology 20:623–630CrossRefPubMed
6.
Zurück zum Zitat Janda M, Steginga S, Langbecker D, Dunn J, Walker D et al (2007) Quality of life among patients with a brain tumor and their carers. J Psychosom Res 63:617–623CrossRefPubMed Janda M, Steginga S, Langbecker D, Dunn J, Walker D et al (2007) Quality of life among patients with a brain tumor and their carers. J Psychosom Res 63:617–623CrossRefPubMed
7.
Zurück zum Zitat Struik K, Klein M, Heimans JJ, Gielissen MF, Bleijenberg G et al (2009) Fatigue in low-grade glioma. J Neurooncol 92:73–78CrossRefPubMed Struik K, Klein M, Heimans JJ, Gielissen MF, Bleijenberg G et al (2009) Fatigue in low-grade glioma. J Neurooncol 92:73–78CrossRefPubMed
8.
Zurück zum Zitat Walbert T (2014) Integration of palliative care into the neuro-oncology practice: patterns in the United States. Neurooncol Pract 1:3–7PubMedPubMedCentral Walbert T (2014) Integration of palliative care into the neuro-oncology practice: patterns in the United States. Neurooncol Pract 1:3–7PubMedPubMedCentral
9.
Zurück zum Zitat Dirven L, Taphoorn MJ, Reijneveld JC, Blazeby J, Jacobs M et al (2014) The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: a systematic review. Eur J Cancer 50:2432–2448CrossRefPubMed Dirven L, Taphoorn MJ, Reijneveld JC, Blazeby J, Jacobs M et al (2014) The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: a systematic review. Eur J Cancer 50:2432–2448CrossRefPubMed
10.
Zurück zum Zitat Koekkoek JA, Dirven L, Reijneveld JC, Sizoo EM, Pasman HR et al (2014) End of life care in high-grade glioma patients in three European countries: a comparative study. J Neurooncol 120:303–310CrossRefPubMed Koekkoek JA, Dirven L, Reijneveld JC, Sizoo EM, Pasman HR et al (2014) End of life care in high-grade glioma patients in three European countries: a comparative study. J Neurooncol 120:303–310CrossRefPubMed
11.
12.
Zurück zum Zitat Luckett T, King MT, Butow PN, Oguchi M, Rankin N et al (2011) Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol 22:2179–2190CrossRefPubMed Luckett T, King MT, Butow PN, Oguchi M, Rankin N et al (2011) Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol 22:2179–2190CrossRefPubMed
13.
Zurück zum Zitat Heimans JJ, Taphoorn MJ (2002) Impact of brain tumour treatment on quality of life. J Neurol 249:955–960CrossRefPubMed Heimans JJ, Taphoorn MJ (2002) Impact of brain tumour treatment on quality of life. J Neurol 249:955–960CrossRefPubMed
14.
Zurück zum Zitat Sprangers MA, Cull A, Bjordal K, Groenvold M, Aaronson NK (1993) The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life. Qual Life Res 2:287–295CrossRefPubMed Sprangers MA, Cull A, Bjordal K, Groenvold M, Aaronson NK (1993) The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life. Qual Life Res 2:287–295CrossRefPubMed
15.
Zurück zum Zitat Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M et al (2010) An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer 46:1033–1040CrossRefPubMed Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M et al (2010) An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer 46:1033–1040CrossRefPubMed
16.
Zurück zum Zitat Mehnert A, Lehmann C, Schulte T, Koch U (2007) Presence of symptom distress and prostate cancer-related anxiety in patients at the beginning of cancer rehabilitation. Onkologie 30:551–556PubMed Mehnert A, Lehmann C, Schulte T, Koch U (2007) Presence of symptom distress and prostate cancer-related anxiety in patients at the beginning of cancer rehabilitation. Onkologie 30:551–556PubMed
17.
Zurück zum Zitat National Comprehensive Cancer Network (2003) Distress management. Clinical practice guidelines. J Natl Compr Canc Netw 1:344–374CrossRef National Comprehensive Cancer Network (2003) Distress management. Clinical practice guidelines. J Natl Compr Canc Netw 1:344–374CrossRef
18.
Zurück zum Zitat Goebel S, Mehdorn HM (2011) Measurement of psychological distress in patients with intracranial tumours: the NCCN distress thermometer. J Neurooncol 104:357–364CrossRefPubMed Goebel S, Mehdorn HM (2011) Measurement of psychological distress in patients with intracranial tumours: the NCCN distress thermometer. J Neurooncol 104:357–364CrossRefPubMed
19.
Zurück zum Zitat Lehmann C, Koch U, Mehnert A (2012) Psychometric properties of the German version of the Short-Form Supportive Care Needs Survey Questionnaire (SCNS-SF34-G). Support Care Cancer 20:2415–2424CrossRefPubMed Lehmann C, Koch U, Mehnert A (2012) Psychometric properties of the German version of the Short-Form Supportive Care Needs Survey Questionnaire (SCNS-SF34-G). Support Care Cancer 20:2415–2424CrossRefPubMed
20.
Zurück zum Zitat Schildmann EK, Groeneveld EI, Denzel J, Brown A, Bernhardt F et al (2016) Discovering the hidden benefits of cognitive interviewing in two languages: the first phase of a validation study of the Integrated Palliative care Outcome Scale. Palliat Med 30:599–610CrossRefPubMed Schildmann EK, Groeneveld EI, Denzel J, Brown A, Bernhardt F et al (2016) Discovering the hidden benefits of cognitive interviewing in two languages: the first phase of a validation study of the Integrated Palliative care Outcome Scale. Palliat Med 30:599–610CrossRefPubMed
21.
Zurück zum Zitat Catt S, Chalmers A, Fallowfield L (2008) Psychosocial and supportive-care needs in high-grade glioma. Lancet Oncol 9:884–891CrossRefPubMed Catt S, Chalmers A, Fallowfield L (2008) Psychosocial and supportive-care needs in high-grade glioma. Lancet Oncol 9:884–891CrossRefPubMed
22.
Zurück zum Zitat Piil K, Juhler M, Jakobsen J, Jarden M (2015) Daily life experiences of patients with a high-grade glioma and their caregivers: a longitudinal exploration of rehabilitation and supportive care needs. J Neurosci Nurs 47:271–284CrossRefPubMed Piil K, Juhler M, Jakobsen J, Jarden M (2015) Daily life experiences of patients with a high-grade glioma and their caregivers: a longitudinal exploration of rehabilitation and supportive care needs. J Neurosci Nurs 47:271–284CrossRefPubMed
23.
Zurück zum Zitat Sterckx W, Coolbrandt A, Clement P, Borgenon S, Decruyenaere M et al (2015) Living with a high-grade glioma: a qualitative study of patients’ experiences and care needs. Eur J Oncol Nurs 19:383–390CrossRefPubMed Sterckx W, Coolbrandt A, Clement P, Borgenon S, Decruyenaere M et al (2015) Living with a high-grade glioma: a qualitative study of patients’ experiences and care needs. Eur J Oncol Nurs 19:383–390CrossRefPubMed
24.
Zurück zum Zitat Philip J, Collins A, Brand CA, Moore G, Lethborg C et al (2014) “I’m just waiting...”: an exploration of the experience of living and dying with primary malignant glioma. Support Care Cancer 22:389–397CrossRefPubMed Philip J, Collins A, Brand CA, Moore G, Lethborg C et al (2014) “I’m just waiting...”: an exploration of the experience of living and dying with primary malignant glioma. Support Care Cancer 22:389–397CrossRefPubMed
25.
Zurück zum Zitat Halkett GK, Lobb EA, Rogers MM, Shaw T, Long AP et al (2015) Predictors of distress and poorer quality of life in high grade glioma patients. Patient Educ Couns 98:525–532CrossRefPubMed Halkett GK, Lobb EA, Rogers MM, Shaw T, Long AP et al (2015) Predictors of distress and poorer quality of life in high grade glioma patients. Patient Educ Couns 98:525–532CrossRefPubMed
26.
Zurück zum Zitat Goebel S, von Harscher M, Mehdorn HM (2011) Comorbid mental disorders and psychosocial distress in patients with brain tumours and their spouses in the early treatment phase. Support Care Cancer 19:1797–1805CrossRefPubMed Goebel S, von Harscher M, Mehdorn HM (2011) Comorbid mental disorders and psychosocial distress in patients with brain tumours and their spouses in the early treatment phase. Support Care Cancer 19:1797–1805CrossRefPubMed
27.
Zurück zum Zitat Ostgathe C, Gaertner J, Kotterba M, Klein S, Lindena G et al (2010) Differential palliative care issues in patients with primary and secondary brain tumours. Support Care Cancer 18:1157–1163CrossRefPubMed Ostgathe C, Gaertner J, Kotterba M, Klein S, Lindena G et al (2010) Differential palliative care issues in patients with primary and secondary brain tumours. Support Care Cancer 18:1157–1163CrossRefPubMed
28.
Zurück zum Zitat Snyder CF, Herman JM, White SM, Luber BS, Blackford AL et al (2014) When using patient-reported outcomes in clinical practice, the measure matters: a randomized controlled trial. J Oncol Pract 10:e299–e306CrossRefPubMedPubMedCentral Snyder CF, Herman JM, White SM, Luber BS, Blackford AL et al (2014) When using patient-reported outcomes in clinical practice, the measure matters: a randomized controlled trial. J Oncol Pract 10:e299–e306CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Mitchell AJ, Lord K, Slattery J, Grainger L, Symonds P (2012) How feasible is implementation of distress screening by cancer clinicians in routine clinical care? Cancer 118:6260–6269CrossRefPubMed Mitchell AJ, Lord K, Slattery J, Grainger L, Symonds P (2012) How feasible is implementation of distress screening by cancer clinicians in routine clinical care? Cancer 118:6260–6269CrossRefPubMed
30.
Zurück zum Zitat Hickmann AK, Hechtner M, Nadji-Ohl M, Janko M, Reuter AK et al (2016) Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient setting. J Neurooncol 131(1):135–151. doi:10.1007/s11060-016-2280-0 CrossRefPubMed Hickmann AK, Hechtner M, Nadji-Ohl M, Janko M, Reuter AK et al (2016) Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient setting. J Neurooncol 131(1):135–151. doi:10.​1007/​s11060-016-2280-0 CrossRefPubMed
31.
Zurück zum Zitat Renovanz M, Hickmann AK, Coburger J, Kohlmann K, Janko M et al (2016) Assessing psychological and supportive care needs in glioma patients—feasibility study on the use of the Supportive Care Needs Survey Short Form (SCNS-SF34-G) and the Supportive Care Needs Survey Screening Tool (SCNS-ST9) in clinical practice. Eur J Cancer Care (Engl). doi:10.1111/ecc.12598 Renovanz M, Hickmann AK, Coburger J, Kohlmann K, Janko M et al (2016) Assessing psychological and supportive care needs in glioma patients—feasibility study on the use of the Supportive Care Needs Survey Short Form (SCNS-SF34-G) and the Supportive Care Needs Survey Screening Tool (SCNS-ST9) in clinical practice. Eur J Cancer Care (Engl). doi:10.​1111/​ecc.​12598
32.
Zurück zum Zitat Sanson-Fisher R, Girgis A, Boyes A, Bonevski B, Burton L et al (2000) The unmet supportive care needs of patients with cancer. Support Care Rev Group Cancer 88:226–237 Sanson-Fisher R, Girgis A, Boyes A, Bonevski B, Burton L et al (2000) The unmet supportive care needs of patients with cancer. Support Care Rev Group Cancer 88:226–237
33.
Zurück zum Zitat Richardson A, Medina J, Brown V, Sitzia J (2007) Patients’ needs assessment in cancer care: a review of assessment tools. Support Care Cancer 15:1125–1144CrossRefPubMed Richardson A, Medina J, Brown V, Sitzia J (2007) Patients’ needs assessment in cancer care: a review of assessment tools. Support Care Cancer 15:1125–1144CrossRefPubMed
34.
Zurück zum Zitat Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB et al (2013) ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res 22:1889–1905CrossRefPubMed Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB et al (2013) ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res 22:1889–1905CrossRefPubMed
35.
Zurück zum Zitat Armstrong TS, Gilbert MR (2014) Patient reported endpoints for measuring clinical benefit in (high grade glioma) primary brain tumor patients. Curr Treat Options Oncol 15:519–528CrossRefPubMed Armstrong TS, Gilbert MR (2014) Patient reported endpoints for measuring clinical benefit in (high grade glioma) primary brain tumor patients. Curr Treat Options Oncol 15:519–528CrossRefPubMed
36.
Zurück zum Zitat Snyder CF, Garrett-Mayer E, Blackford AL, Brahmer JR, Carducci MA et al (2009) Concordance of cancer patients’ function, symptoms, and supportive care needs. Qual Life Res 18:991–998CrossRefPubMed Snyder CF, Garrett-Mayer E, Blackford AL, Brahmer JR, Carducci MA et al (2009) Concordance of cancer patients’ function, symptoms, and supportive care needs. Qual Life Res 18:991–998CrossRefPubMed
37.
Zurück zum Zitat Janda M, Steginga S, Dunn J, Langbecker D, Walker D et al (2008) Unmet supportive care needs and interest in services among patients with a brain tumour and their carers. Patient Educ Couns 71:251–258CrossRefPubMed Janda M, Steginga S, Dunn J, Langbecker D, Walker D et al (2008) Unmet supportive care needs and interest in services among patients with a brain tumour and their carers. Patient Educ Couns 71:251–258CrossRefPubMed
38.
Zurück zum Zitat Heese O, Schmidt M, Nickel S, Berger H, Goldbrunner R et al (2010) Complementary therapy use in patients with glioma: an observational study. Neurology 75:2229–2235CrossRefPubMed Heese O, Schmidt M, Nickel S, Berger H, Goldbrunner R et al (2010) Complementary therapy use in patients with glioma: an observational study. Neurology 75:2229–2235CrossRefPubMed
39.
Zurück zum Zitat Mulpur BH, Nabors LB, Thompson RC, Olson JJ, LaRocca RV et al (2015) Complementary therapy and survival in glioblastoma. Neurooncol Pract 2:122–126PubMedPubMedCentral Mulpur BH, Nabors LB, Thompson RC, Olson JJ, LaRocca RV et al (2015) Complementary therapy and survival in glioblastoma. Neurooncol Pract 2:122–126PubMedPubMedCentral
40.
Zurück zum Zitat Gaertner J, Wolf J, Frechen S, Klein U, Scheicht D et al (2012) Recommending early integration of palliative care: does it work? Support Care Cancer 20:507–513CrossRefPubMed Gaertner J, Wolf J, Frechen S, Klein U, Scheicht D et al (2012) Recommending early integration of palliative care: does it work? Support Care Cancer 20:507–513CrossRefPubMed
41.
Zurück zum Zitat Gaertner J, Wolf J, Hallek M, Glossmann JP, Voltz R (2011) Standardizing integration of palliative care into comprehensive cancer therapy: a disease specific approach. Support Care Cancer 19:1037–1043CrossRefPubMed Gaertner J, Wolf J, Hallek M, Glossmann JP, Voltz R (2011) Standardizing integration of palliative care into comprehensive cancer therapy: a disease specific approach. Support Care Cancer 19:1037–1043CrossRefPubMed
42.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed
43.
Zurück zum Zitat Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R et al (2013) The frequency, longitudinal course, clinical associations, and causes of emotional distress during primary treatment of cerebral glioma. Neuro Oncol 15:635–643CrossRefPubMedPubMedCentral Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R et al (2013) The frequency, longitudinal course, clinical associations, and causes of emotional distress during primary treatment of cerebral glioma. Neuro Oncol 15:635–643CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Sinclair S, Norris JM, McConnell SJ, Chochinov HM, Hack TF et al (2016) Compassion: a scoping review of the healthcare literature. BMC Palliat Care 15:6CrossRefPubMedPubMedCentral Sinclair S, Norris JM, McConnell SJ, Chochinov HM, Hack TF et al (2016) Compassion: a scoping review of the healthcare literature. BMC Palliat Care 15:6CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Tanco K, Rhondali W, Perez-Cruz P, Tanzi S, Chisholm GB et al (2015) Patient perception of physician compassion after a more optimistic vs. a less optimistic message: a randomized clinical trial. JAMA Oncol 1:176–183CrossRefPubMed Tanco K, Rhondali W, Perez-Cruz P, Tanzi S, Chisholm GB et al (2015) Patient perception of physician compassion after a more optimistic vs. a less optimistic message: a randomized clinical trial. JAMA Oncol 1:176–183CrossRefPubMed
46.
Zurück zum Zitat Faller H, Weis J, Koch U, Brahler E, Harter M et al (2016) Perceived need for psychosocial support depending on emotional distress and mental comorbidity in men and women with cancer. J Psychosom Res 81:24–30CrossRefPubMed Faller H, Weis J, Koch U, Brahler E, Harter M et al (2016) Perceived need for psychosocial support depending on emotional distress and mental comorbidity in men and women with cancer. J Psychosom Res 81:24–30CrossRefPubMed
47.
Zurück zum Zitat Rooney AG, van Nieuwenhuizen D, Reijneveld JC, Grant R (2009) Female gender is not a proven risk factor for depression in glioma. J Neurooncol 95:449CrossRefPubMed Rooney AG, van Nieuwenhuizen D, Reijneveld JC, Grant R (2009) Female gender is not a proven risk factor for depression in glioma. J Neurooncol 95:449CrossRefPubMed
48.
Zurück zum Zitat Quinten C, Coens C, Ghislain I, Zikos E, Sprangers MA et al (2015) The effects of age on health-related quality of life in cancer populations: a pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients. Eur J Cancer 51:2808–2819CrossRefPubMed Quinten C, Coens C, Ghislain I, Zikos E, Sprangers MA et al (2015) The effects of age on health-related quality of life in cancer populations: a pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients. Eur J Cancer 51:2808–2819CrossRefPubMed
49.
Zurück zum Zitat Boele FW, Klein M, Reijneveld JC, Verdonck-de Leeuw IM, Heimans JJ (2014) Symptom management and quality of life in glioma patients. CNS Oncol 3:37–47CrossRefPubMed Boele FW, Klein M, Reijneveld JC, Verdonck-de Leeuw IM, Heimans JJ (2014) Symptom management and quality of life in glioma patients. CNS Oncol 3:37–47CrossRefPubMed
50.
Zurück zum Zitat Peters KB, West MJ, Hornsby WE, Waner E, Coan AD et al (2014) Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients. J Neurooncol 120:499–506CrossRefPubMedPubMedCentral Peters KB, West MJ, Hornsby WE, Waner E, Coan AD et al (2014) Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients. J Neurooncol 120:499–506CrossRefPubMedPubMedCentral
Metadaten
Titel
Factors associated with supportive care needs in glioma patients in the neuro-oncological outpatient setting
verfasst von
Mirjam Renovanz
Marlene Hechtner
Mareile Janko
Karoline Kohlmann
Jan Coburger
Minou Nadji-Ohl
Jochem König
Florian Ringel
Susanne Singer
Anne-Katrin Hickmann
Publikationsdatum
19.05.2017
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 3/2017
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-017-2484-y

Weitere Artikel der Ausgabe 3/2017

Journal of Neuro-Oncology 3/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.